Hydroxyapatite (HA) bio-ceramic ocular implants ensure superior biocompatibility, optimized structural integrity, and reliable integration with soft tissues. Designed for ophthalmic applications, they enhance healing efficiency, provide natural aesthetics, and ensure long-term durability.
Product Overview
The Hydroxyapatite (HA) bio-ceramic ocular implant is a porous structure artificial implant designed for the restoration and correction following eyeball enucleation. Made from high-purity hydroxyapatite, this material has excellent biocompatibility with human bone tissue, ensuring a smooth integration with the surrounding tissues. It is non-toxic, non-antigenic, and lightweight, addressing the issues of traditional ocular implants like slippage and restricted movement. The surface of the implant has a controlled porous microstructure that promotes blood vessel growth and long-term biological integration with the surrounding tissue. With this implant, the prosthetic eye retains good mobility, reduces post-operative complications, and provides a more natural appearance of the eye.
Key Features
- High Purity (>95%) Hydroxyapatite: Ensures excellent biocompatibility and compatibility with human bone tissue.
- Porous Microstructure: Pore diameter of 500+200μm and connection diameter of 150+50μm promotes vascular and tissue growth.
- High Porosity (>70%): Lightweight, supports the mobility of the prosthetic eye, and prevents eyelid sagging.
- Smooth Surface: Facilitates easy implantation and reduces post-operative complications.
- Strong Tissue Integration: Ensures long-lasting integration with host tissue, preventing displacement and rejection.
Applications
- Post-Enucleation Repair: Ideal for patients who have undergone eyeball enucleation due to trauma, tumor, or infection.
- Eye Atrophy, Deformity, and Eyelid Depression Repair: Suitable for correcting eye atrophy or deformities and repairing eyelid retraction.
- Long-Term Fill for Ocular Surgeries: Provides an ideal solution for filling and restoring the eye socket in ocular surgeries, addressing the issues of heavy traditional implants and lack of tissue growth in older models.